Recorded Chinese product: 盐酸利多卡因氯化钠注射液盐酸利多卡因氯化钠注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 北京市永康药业有限公司Chinese legal name: 北京市永康药业有限公司
主要成分Active Ingredients
- 利多卡因Liduo Kayin
药物知识说明
利多卡因是一种在国家药监局注册认定的药品。该药品含有利多卡因-c221ea43等成分。
该药品关联的活性成分包括：利多卡因Liduo Kayin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：北京市永康药业有限公司Chinese legal name: 北京市永康药业有限公司。
您可以探索含有相同成分的其他药品：利多卡因-c221ea43成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸利多卡因氯化钠注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 利多卡因Liduo Kayin.
Manufacturers recorded for this product: 北京市永康药业有限公司Chinese legal name: 北京市永康药业有限公司.
Explore other medicines containing the same ingredient: 利多卡因 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸利多卡因氯化钠注射液Recorded Chinese product: 盐酸利多卡因氯化钠注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml：盐酸利多卡因5mg，氯化钠17mg。Recorded Chinese description: 2ml：盐酸利多卡因5mg，氯化钠17mg。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 北京市永康药业有限公司Chinese legal name: 北京市永康药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H11022486
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H11022486
Manufacturer
Chinese legal name: 北京市永康药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H11022486
生产企业
北京市永康药业有限公司(国产)
适应症
局部麻醉药。作肌注用青霉素溶媒，可减轻注射部位疼痛。5―15分钟起效，吸收完全。
用法用量
用本品将注射用青霉素溶解，供肌内注射。一般情况下一次一支，使青霉素安全溶解即可。推荐用量最多不超过两支。
不良反应
本品在推荐最大用量范围内远未达中毒血药浓度（5μg/ml）。但应注意交叉过敏反应：有红斑皮疹及血管神经性水肿等表现应停药，严重者可致呼吸停止，皮肤试验对预测过敏反应价值有限。
禁忌
婴儿、严重心脏阻滞患者、严重窦房节功能障碍患者禁用。
注意事项
对其他胺类局麻药过敏者，可能对本品也过敏，但本品与普鲁卡因、奎尼丁间尚无交叉过敏反应的报道。
贮藏
密闭保存
规格
2ml：盐酸利多卡因5mg，氯化钠17mg。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.